Skip to content

Study for intestinal bacterial overgrowth and complications during pregnancy

Study for Intestinal Microecology and Pregnancy Complications

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026326
Enrollment
Unknown
Registered
2019-09-30
Start date
2017-12-01
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

complications during pregnancy

Interventions

Sponsors

Third Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Compliance with the diagnostic criteria for complications of pregnancy formulated by the World Health Organization (WHO); 2. Pregnant women without pregnancy complications were selected as control group during pregnancy.

Exclusion criteria

Exclusion criteria: 1. Aged <18 years old; 2. combined with other complications of pregnancy complications; 3. patients with diabetes, obesity, polycystic ovary syndrome before pregnancy; 4. There are serious stress events; 5. severe anxiety, depression; 6. long-term constipation; 7. accompanied by circulatory system, digestive system and other medical history; 8. had been associated with severe intestinal disease or had undergone bowel surgery; 9. long-term use of antibiotics or regulation of intestinal flora drugs; 10. used antidiarrheal drugs, probiotics and antibiotics in the past 2 weeks; 11. There are special habits such as taking yogurt or probiotic products every day; 12. stool routine examination abnormalities.

Design outcomes

Primary

MeasureTime frame
16S sequencing;Proteomics;Complications during pregnancy;Intestinal flora;

Countries

China

Contacts

Public ContactYajuan Xu

Third Affiliated Hospital of Zhengzhou University

cnzzzsl@163.com+86 15936229276

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026